Yue Zhang

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts

Lijun Ning, Yilu Zhou, Han Sun et al. · Nature Communications · 2023 · 234 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Mitigation of China’s carbon neutrality to global warming

Longhui Li, Yue Zhang, Tianjun Zhou et al. · Nature Communications · 2022 · 184 citations · Full text

Natural Sciences, Environmental Sciences, Climate Change Mitigation +14

Mesenchymal Stem Cell‐Derived Extracellular Vesicles with High PD‐L1 Expression for Autoimmune Diseases Treatment

Fang Xu, Ziying Fei, Huaxing Dai et al. · Advanced Materials · 2021 · 172 citations

Life Sciences, Cell Biology, Immunology +15

Tumor‐Microenvironment‐Activatable Polymer Nano‐Immunomodulator for Precision Cancer Photoimmunotherapy

Jing Liu, Shasha He, Ying‐Li Luo et al. · Advanced Materials · 2021 · 148 citations

Medicine, Immunology, Oncology +17